×
About 2,989 results

ALLMedicine™ Transferrin Receptor Center

Research & Reviews  1,493 results

Focused Ultrasound and Microbubble Treatment Increases Delivery of Transferrin Receptor...
https://doi.org/10.1016/j.ultrasmedbio.2021.01.014
Ultrasound in Medicine & Biology; Olsman M, Sereti V et. al.

Feb 20th, 2021 - The blood-brain barrier (BBB) is a major obstacle to treating several brain disorders. Focused ultrasound (FUS) in combination with intravascular microbubbles increases BBB permeability by opening tight junctions, creating endothelial cell opening...

Nanoparticles that do not compete with endogenous ligands - Molecular characterization ...
https://doi.org/10.1016/j.jconrel.2021.02.009
Journal of Controlled Release : Official Journal of the C... Zou D, Arora M et. al.

Feb 18th, 2021 - A vast majority, if not all of the receptor-mediated drug delivery systems utilize nanoparticles that are conjugated to physiological mimic ligands, with testing restricted to in vitro and rodent models. In this report, we present for the first ti...

Defective palmitoylation of transferrin receptor triggers iron overload in Friedreich's...
https://doi.org/10.1182/blood.2020006987
Blood Petit F, Drecourt A et. al.

Feb 2nd, 2021 - Friedreich's ataxia (FRDA) is a frequent autosomal recessive disease caused by a GAA repeat expansion in the FXN gene encoding frataxin, a mitochondrial protein involved in iron-sulfur cluster (ISC) biogenesis. Resulting frataxin deficiency affect...

MYCN-amplified neuroblastoma is addicted to iron and vulnerable to inhibition of the sy...
https://doi.org/10.1158/0008-5472.CAN-20-1641
Cancer Research; Floros KV, Cai J et. al.

Jan 23rd, 2021 - MYCN is amplified in 20-25% of neuroblastoma, and MYCN-amplified neuroblastoma contributes to a large percent of pediatric cancer-related deaths. Therapy improvements for this subtype of cancer is a high priority. Here we uncover a MYCN-dependent ...

see more →

Clinicaltrials.gov  1,495 results

Focused Ultrasound and Microbubble Treatment Increases Delivery of Transferrin Receptor...
https://doi.org/10.1016/j.ultrasmedbio.2021.01.014
Ultrasound in Medicine & Biology; Olsman M, Sereti V et. al.

Feb 20th, 2021 - The blood-brain barrier (BBB) is a major obstacle to treating several brain disorders. Focused ultrasound (FUS) in combination with intravascular microbubbles increases BBB permeability by opening tight junctions, creating endothelial cell opening...

Nanoparticles that do not compete with endogenous ligands - Molecular characterization ...
https://doi.org/10.1016/j.jconrel.2021.02.009
Journal of Controlled Release : Official Journal of the C... Zou D, Arora M et. al.

Feb 18th, 2021 - A vast majority, if not all of the receptor-mediated drug delivery systems utilize nanoparticles that are conjugated to physiological mimic ligands, with testing restricted to in vitro and rodent models. In this report, we present for the first ti...

Defective palmitoylation of transferrin receptor triggers iron overload in Friedreich's...
https://doi.org/10.1182/blood.2020006987
Blood Petit F, Drecourt A et. al.

Feb 2nd, 2021 - Friedreich's ataxia (FRDA) is a frequent autosomal recessive disease caused by a GAA repeat expansion in the FXN gene encoding frataxin, a mitochondrial protein involved in iron-sulfur cluster (ISC) biogenesis. Resulting frataxin deficiency affect...

MYCN-amplified neuroblastoma is addicted to iron and vulnerable to inhibition of the sy...
https://doi.org/10.1158/0008-5472.CAN-20-1641
Cancer Research; Floros KV, Cai J et. al.

Jan 23rd, 2021 - MYCN is amplified in 20-25% of neuroblastoma, and MYCN-amplified neuroblastoma contributes to a large percent of pediatric cancer-related deaths. Therapy improvements for this subtype of cancer is a high priority. Here we uncover a MYCN-dependent ...

see more →

News  1 results

Biological Response Modifiers in Cancer
https://www.medscape.com/viewarticle/545538_10

Nov 13th, 2006 - Epratuzumab Epratuzumab (LL2) is a murine IgG2a antibody targeted against CD22 antigen (transferrin receptor). It is widely expressed during B-cell development and is present in most of NHL tumours[64] Juweid and colleagues[65] compared 131ILL2 wi...

see more →